GlaxoSmithKline's Boostrix and Adacel vaccines, which prevent pertussis, or whooping cough, in adolescents and adults, have been recommended for approval by an FDA expert panel. Children are immunized against diphtheria, tetanus and whooping cough in their first months, but the immunity against whooping cough wears off; the panel recommended Boostrix for 10- to 18-year-olds and Adacel for people between ages 11 and 64.

Full Story:

Related Summaries